Logo Logo Logo Logo Logo Logo
  • Home
  • Team
  • Technology
  • Translation
  • News
  • Partnering
  • Funding
  • Career

Author: p539124

16 April, 2025 in Uncategorized
Pantherna Therapeutics Secures Japanese Patent for PTXmRNA® Technology
25 October, 2024 in Uncategorized
Pantherna Therapeutics and TQ Therapeutics announce research collaboration to advance ultra-short Cell and Gene Therapy (CGT) process leveraging LNP technology
26 September, 2024 in Uncategorized
Pantherna Announces Research collaboration with Bayer to Advance LNP Technology for Beyond Liver mRNA Therapy
01 August, 2024 in Uncategorized
BioSpring and Pantherna agree on strategic cooperation in the field of genome editing
03 May, 2024 in Allgemein
Company update: Ansgar Santel appointed as new CEO
05 April, 2024 in Uncategorized
Pantherna and WACKER Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals
27 December, 2023 in Allgemein
Press release grant of EP patent
25 October, 2023 in Allgemein
New article alert: “Cationic LNP-formulated mRNA expressing Tie2-agonist in the lung endothelium prevents pulmonary vascular leakage”.
11 October, 2023 in Allgemein
New article alert: “The PTXΔLNP® Platform: On the Promise of Developing New LNPs for Tomorrow’s mRNA Therapies”.
07 June, 2023 in Allgemein
Pantherna Therapeutics teams up with University Medicine Rostock (UMR) on exploring new opportunities for mRNA therapy in ocular disease
  • 1
  • 2
  • 3
  • 4
Privacy Policy | Imprint
Diese Website benutzt Cookies. Wenn du die Website weiter nutzt, gehen wir von deinem Einverständnis aus.OKNeinDatenschutzerklärung